| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/25/2013 | CN103463155A Pharmaceutical composition used for preventing birth defects and improving memory |
| 12/25/2013 | CN103463146A Pharmaceutical composition for preventing birth defects and improving memory |
| 12/25/2013 | CN103463145A Ginkgo leaf refinement extract adopting ginkgo fallen leaves as raw material, preparation method and application thereof |
| 12/25/2013 | CN103463133A Material including royal jelly-decomposing enzyme |
| 12/25/2013 | CN103463129A Pharmaceutical composition used for preventing birth defects and improving memory |
| 12/25/2013 | CN103463123A Method for extracting effective constituents from maca |
| 12/25/2013 | CN103463120A Stable-type composite vitamin B tablet and preparation method thereof |
| 12/25/2013 | CN103463118A Application of geniposide in preparation of parkinsonism disease treatment medicines |
| 12/25/2013 | CN103463103A Application of Kadcoccitones A in preparing medicament for treating alzheimer disease |
| 12/25/2013 | CN103463087A Preparation method of night cold-treating soft capsules |
| 12/25/2013 | CN103462990A Application of Aphanamgrandiol A in preparation of anti-depressant medicaments |
| 12/25/2013 | CN103462975A Inclusion compound of mangiferin and alkaline cyclodextrin |
| 12/25/2013 | CN103462940A Huperzine A micro-emulsion type cataplasm |
| 12/25/2013 | CN103462936A Tablet capsule filled with topiramate tablets |
| 12/25/2013 | CN103462913A Galenic formulations of organic compounds |
| 12/25/2013 | CN103462886A Stable levetiracetam injection |
| 12/25/2013 | CN103462851A Head wind removing shampoo formula |
| 12/25/2013 | CN103055216B Three-original ecology tracing conjugate bonesetting reduction health traditional Chinese medicine preparation and preparation method thereof |
| 12/25/2013 | CN103007028B Formula and preparation method of medicine used for preventing and treating sleeplessness mental disease |
| 12/25/2013 | CN103006606B Piribedil sustained-release tablet and preparation method thereof |
| 12/25/2013 | CN102920998B Application of Chinese yarn glycoprotein in improvement of activities of oxidative metabolism enzymes of mitochondria of brain cell |
| 12/25/2013 | CN102784319B Method for preparing traditional Chinese medicine for treating insomnia caused by deficiency of both qi and yin |
| 12/25/2013 | CN102671007B Medicament for treating senile dementia and preparation method thereof |
| 12/25/2013 | CN102670615B Application of 6-benzyl aminopurine compound in terms of preparation of composition for suppressing oxidative injury to brain tissues |
| 12/25/2013 | CN102603868B Synthetic polypeptide and application of synthetic polypeptide |
| 12/25/2013 | CN102552188B Agomelatine tablet and preparation method thereof, as well as coated tablet of agomelatine tablet and preparation method thereof |
| 12/25/2013 | CN102512578B Dripping core pill preparation with effect of relieving sore throat and preparation method thereof |
| 12/25/2013 | CN102504006B Steroid saponin compound in siberian fritillary bulb |
| 12/25/2013 | CN102470136B PLK inhibitor salts |
| 12/25/2013 | CN102249975B (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide crystal form I and preparation method and application thereof |
| 12/25/2013 | CN102212014B Crystal form of O-demethyl-venlafaxine glutamate, preparation method and medicinal application thereof |
| 12/25/2013 | CN102164920B Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 12/25/2013 | CN102085209B Medicinal composition for treating senile dementia |
| 12/25/2013 | CN102085194B Levetiracetam oral disintegrating tablet and preparation method thereof |
| 12/25/2013 | CN102049048B Method of treatment or prophylaxis |
| 12/25/2013 | CN102046596B Substituted cyclohexyldiamines |
| 12/25/2013 | CN102038866B Traditional Chinese medicine extract for treating neuropathic pain and preparation thereof |
| 12/25/2013 | CN102028754B Method for rapidly preparing total lignans and total saponins from schisandra chinensis |
| 12/25/2013 | CN101747170B Conjugated type coenzyme Q analogue, preparation method and application thereof |
| 12/25/2013 | CN101679430B 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of ORL-i receptor for treatment of anxiety and depression |
| 12/25/2013 | CN101611054B Humanized antibody against amyloid beta |
| 12/24/2013 | US8614232 Injectable depot formulation comprising crystals of iloperidone |
| 12/24/2013 | US8614219 Substituted pyrimidin-4-one derivatives |
| 12/24/2013 | US8613929 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers |
| 12/24/2013 | US8613928 Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein |
| 12/24/2013 | US8613927 High affinity human antibodies to human nerve growth factor |
| 12/24/2013 | CA2625642C Prolinamide derivatives as sodium channel modulators |
| 12/24/2013 | CA2602787C Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 12/24/2013 | CA2560047C Substituted imidazoles and their use as opioid receptor modulators |
| 12/24/2013 | CA2554082C Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism |
| 12/24/2013 | CA2397199C Nogo receptor-mediated blockade of axonal growth |
| 12/24/2013 | CA2393816C Process for obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ros scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 12/24/2013 | CA2375104C Prevention and treatment of amyloidogenic disease |
| 12/19/2013 | WO2013188881A1 Compounds, compositions and methods for treating or preventing neurodegenerative disorders |
| 12/19/2013 | WO2013188724A1 Azetidine and piperidine compounds useful as pde10 inhibitors |
| 12/19/2013 | WO2013188666A1 Beta-2 chimaerin as a mediator of axonal and synaptic pruning |
| 12/19/2013 | WO2013188509A1 Seizure therapy |
| 12/19/2013 | WO2013188214A1 Compounds for treating inflammation and pain |
| 12/19/2013 | WO2013187795A1 Pharmaceutical composition of an s1p receptor agonist for treating demyelinized disorders |
| 12/19/2013 | WO2013187612A1 Composition for restricting apoptosis, including mirna of epstein-barr virus, or promoting cell proliferation |
| 12/19/2013 | WO2013187503A1 Glycine transporter inhibitor |
| 12/19/2013 | WO2013187467A1 Heteroaromatic methyl cyclic amine derivative |
| 12/19/2013 | WO2013187466A1 Branched chain alkyl heteroaromatic ring derivative |
| 12/19/2013 | WO2013187451A1 Patch |
| 12/19/2013 | WO2013187075A1 Prophylactic and/or therapeutic agent for mild cognitive impairment |
| 12/19/2013 | WO2013186766A1 Extracts and therapeutic uses thereof |
| 12/19/2013 | WO2013186666A1 Tricyclic compounds as kat ii inhibitors |
| 12/19/2013 | WO2013186220A1 Compositions comprising hesperidin and/or apigenin i.a. for medical use or for use in treatment of sleeping disorders |
| 12/19/2013 | WO2013185505A1 Olanzapine oral instant membrane |
| 12/19/2013 | WO2013185353A1 Compound as wnt signaling inhibitor, composition, and use thereof |
| 12/19/2013 | WO2013185301A1 Use of flavone and flavanone derivatives in preparation of sedative and hypnotic drugs |
| 12/19/2013 | WO2013185209A1 Forms of vilazodone and processes for the preparation thereof |
| 12/19/2013 | WO2013185187A1 Gastrin-releasing peptide receptor-based methods for the treatment of stereotypies, social behavior deficits, and compulsive behaviors associated with neuropsychiatry and neurodevelopmental disorders and pharmaceutical composition containing grp |
| 12/19/2013 | US20130338200 Pharmaceutical dosage forms of tizanidine and administration routes thereof |
| 12/19/2013 | US20130338188 Pharmaceutical compositions and administrations thereof |
| 12/19/2013 | US20130338186 Amides of acetic and propionic acids |
| 12/19/2013 | US20130337549 Materials and methods for nerve grafting |
| 12/19/2013 | US20130337052 System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication |
| 12/19/2013 | CA2876902A1 Compositions and methods for transmucosal absorption |
| 12/19/2013 | CA2876741A1 Forms of vilazodone and processes for the preparation thereof |
| 12/19/2013 | CA2876371A1 Prophylactic and/or therapeutic agent for mild cognitive impairment |
| 12/19/2013 | CA2876253A1 Heteroaromatic methyl cyclic amine derivative |
| 12/19/2013 | CA2876249A1 Branched chain alkyl heteroaromatic ring derivative |
| 12/19/2013 | CA2875802A1 Azetidine and piperidine compounds useful as pde10 inhibitors |
| 12/19/2013 | CA2875372A1 Compound as wnt signaling inhibitor, composition, and use thereof |
| 12/19/2013 | CA2875198A1 Compounds for treating inflammation and pain |
| 12/18/2013 | EP2674434A1 Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators |
| 12/18/2013 | EP2674433A1 LIMK2 inhibitors, compositions comprising them and methods of their use |
| 12/18/2013 | EP2673635A2 Apoe immunotherapy |
| 12/18/2013 | EP2673287A1 Amino statin derivatives for the treatment of arthrosis |
| 12/18/2013 | EP2673279A1 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
| 12/18/2013 | EP2673278A1 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors |
| 12/18/2013 | EP2673266A1 Phenothiazine diaminium salts and their use |
| 12/18/2013 | EP2673048A2 Treatment of bipolar disorder |
| 12/18/2013 | EP2672987A1 Use of creatine kinase for preventing or treating addiction to opiates |
| 12/18/2013 | EP2672974A1 Hybrid opioid compounds and compositions |
| 12/18/2013 | EP2672973A1 Administration regime for nitrocatechols |
| 12/18/2013 | EP2672823A1 S1p modulating agents |
| 12/18/2013 | EP2672822A1 Methods and compositions for improving cognitive function |
| 12/18/2013 | EP2491034B1 Fused heterocyclic compounds as orexin receptor modulators |